11α- and 11β-hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat

Hypertension

Volumn 27, Issue 3 I, 1996, Pages 421-425

  Souness, Graham W ^a   Morris, David J ^b  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

11 hydroxysteroid dehydrogenase; corticosterone; hypertension, experimental; progesterone

Indexed keywords

11ALPHA HYDROXYPROGESTERONE; 11BETA HYDROXYPROGESTERONE; 11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTEROID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029968764     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.3.421     Document Type: Article

References (35)

1. + retention. Steroids. 1994;59:352-356.
2. Jenkins JS. The metabolism of cortisol by human extra-hepatic tissues. J Endocrinol. 1966;34:51-56.
3. Bush IE, Hunter SA, Meigs RA. Metabolism of 11-oxygenated steroids. Biochem J. 1968;107:239-257.
4. Monder C, Lakshimi V. Evidence for kinetically distinct forms of corticosterone 11β-dehydrogenase in rat liver microsomes. J Steroid Biochem. 1989;32:77-83.
5. Rusvai E, Naray-Fejes-Toth A. A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem. 1993;268:10717-10720.
6. Edwards CRW, Burt D, McIntyre MA, DeKloet ER, Stewart PM, Brett L, Sutanto WS, Monder C. Localization of 11β-hydroxysteroid dehydrogenase: tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
7. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme not receptor mediated. Science. 1988;242:583-585.
8. Stewart PM, Valentine R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of licorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987;2: 821-824.
9. Souness GW, Morris DJ. The antinatriuretic and kaliuretic effects of corticosterone and cortisol following pretreatment with carbenoxolone sodium (a licorice derivative) in the adrenalectomized rat. Endocrinology: 1989;124:1588-1590.
10. Kornel L, Starnes WR, Hill SR Jr, Hill A. Studies on steroid conjugates, VI: quantitative paper chromatography of urinary corticosteroids in essential hypertension. J Clin Endocrinol Metab. 1969;29:1608-1617.
11. Kornel L, Margolis E. Evidence for overall deficiency of cortisol 11β-hydroxy dehydrogenase in patients with essential hypertension. In: Proceedings of the 9th International Congress of Endocrinology; September 1992; Nice, France. Abstract P-04.31.123.
12. Walker BR, Connacher AA, Webb DJ, Edwards CRW. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci. 1992;83:171-178.
13. Gomez-Sanchez EP, Gomez-Sanchez CE. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol. 1992;263:E1125-E1130.
14. Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension. Hypertension. 1995;25:67-70.
15. Monder C, White PC. 11β-Hydroxysteroid dehydrogenase. Vitam Harm. 1993;47:187-269.
16. Brem AS, Bina B, King T, Morris DJ. Bidirectional activity of 11β-hydroxysteroid dehydrogenase in vascular smooth muscle cells. Steroids. 1995;60:406-410.
17. Naray-Fejes-Toth A, Watlington CO, Fejes-Toth G. 11β-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology. 1991;129:17-21.
18. Kenouch S, Alfaidy N, Bonvalet JP, Farman N. Expression of 11β-OHSD along the nephron of mammals and humans. Steroids. 1994;59:100-104.
19. +-dependent 11β-hydroxysteroid dehydrogenase in sheep kidney and JEG-3 cells. In: Proceedings of the Endocrine Society 77th Annual Meeting; June 7-11, 1995; Washington, DC. Abstract P2-490.
20. Souness GW, Latif SA, Laurenzo JL, Morris DJ. 11α- and 11β-Hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat. Endocrinology. 1995;136:1809-1812.
21. Kenyon CJ, DeConti GA, Cupolo NA, Morris DJ. The role of aldosterone in the development of hypertension in spontaneously hypertensive rats. Endocrinology. 1981;109:1841-1845.
22. Ulick S, Ramires LC, New MI. An abnormality in steroid reductive metabolism in a hypertensive syndrome. J Clin Endocrinol Metab. 1977;44:799-802.
23. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New M. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab. 1979;49:757-764.
24. Oberfield SE, Levine RM, Carvey RM, Greig F, Ulick S, New MI. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 1983;56:332-339.
25. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol. 1993;39:221-227.
26. Souness GW, Morris DJ. The 'mineralocorticoid-like' actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318. Endocrinology. 1991;129:2451-2456.
27. + transport in toad bladder. Am J Physiol. 1989;26:F700-F704.
28. Gaeggeler HP, Edwards CRW, Rossier BC. Steroid metabolism determines mineralocorticoid specificity in toad bladder. Am J Physiol. 1989;257:F690-F695.
29. Gomez-Sanchez EP. Mineralocorticoid modulation of central control of blood pressure. Steroids. 1995;60:69-72.
30. Funder JW, Pearce PT, Myles K, Roy LP. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a new definition of mineralocorticoid action. FASEB J. 1990;4:3234-3238.
31. Moisan MP, Seckl JR, Edwards CRW. 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology. 1990;127:1450-1455.
32. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC, Edwards CRW. 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129:3305-3312.
33. Chapman TE, Kraan GP, Nagel GT, Wolthers BG, Drayer NM. Measurement of the cortisol production rate in two sisters with 17α-hydroxylase deficiency using [1,2,3,4-13C]cortisol and isotope dilution mass spectrometry. J Steroid Biochem Mol Biol. 1991;38:489-496.
34. New MI, Levine LS. Hypertension of childhood with suppressed renin. Endocr Rev. 1980;1:421-429.
35. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinology. 1994;135:2283-2286.